165 related articles for article (PubMed ID: 18157394)
81. Correlation between serum calcium levels and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism.
Mshelia DS; Hatutale AN; Mokgoro NP; Nchabaleng ME; Buscombe JR; Sathekge MM
Clin Physiol Funct Imaging; 2012 Jan; 32(1):19-24. PubMed ID: 22136277
[TBL] [Abstract][Full Text] [Related]
82. Two-phase scintigraphy with technetium 99m-sestamibi in patients with hyperparathyroidism due to chronic renal failure.
Muros MA; Bravo Soto J; López Ruiz JM; Rodríguez-Portillo M; Ramírez Navarro A; Bellón Guardia M; Perán F; Llamas-Elvira JM
Am J Surg; 2007 Apr; 193(4):438-42. PubMed ID: 17368284
[TBL] [Abstract][Full Text] [Related]
83. Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure.
Chesser AM; Carroll MC; Lightowler C; Macdougall IC; Britton KE; Baker LR
Nephrol Dial Transplant; 1997 Jan; 12(1):97-100. PubMed ID: 9027781
[TBL] [Abstract][Full Text] [Related]
84. [Localisation of parathyroid glands using planar (99m)Tc-sestamibi scintigraphy. Comparison between subtraction- and dual-phase technique].
Schommartz B; Cupisti K; Antke C; Schmidt D; Knoefel WT; Müller HW
Nuklearmedizin; 2006; 45(3):115-21. PubMed ID: 16710507
[TBL] [Abstract][Full Text] [Related]
85. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
86. Preoperative parathyroid localization: prospective evaluation of technetium 99m sestamibi.
Khan A; Samtani S; Varma VM; Frost A; Cohen J
Otolaryngol Head Neck Surg; 1994 Oct; 111(4):467-72. PubMed ID: 7936680
[TBL] [Abstract][Full Text] [Related]
87. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
O'Doherty MJ; Kettle AG; Wells P; Collins RE; Coakley AJ
J Nucl Med; 1992 Mar; 33(3):313-8. PubMed ID: 1531500
[TBL] [Abstract][Full Text] [Related]
88. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.
Soman P; Taillefer R; DePuey EG; Udelson JE; Lahiri A
J Am Coll Cardiol; 2001 Feb; 37(2):458-62. PubMed ID: 11216963
[TBL] [Abstract][Full Text] [Related]
89. Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies.
Aigner RM; Fueger GF; Nicoletti R
Eur J Nucl Med; 1996 Jun; 23(6):693-6. PubMed ID: 8662105
[TBL] [Abstract][Full Text] [Related]
90. Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?
Tublin ME; Pryma DA; Yim JH; Ogilvie JB; Mountz JM; Bencherif B; Carty SE
J Ultrasound Med; 2009 Feb; 28(2):183-90. PubMed ID: 19168768
[TBL] [Abstract][Full Text] [Related]
91. Value of sestamibi scans in tertiary hyperparathyroidism.
Loftus KA; Anderson S; Mulloy AL; Terris DJ
Laryngoscope; 2007 Dec; 117(12):2135-8. PubMed ID: 17891049
[TBL] [Abstract][Full Text] [Related]
92. Parathyroid scintigraphy: first experiences with technetium (III)-99m-Q12.
Aigner RM; Fueger GF; Wolf G
Eur J Nucl Med; 1997 Mar; 24(3):326-9. PubMed ID: 9143473
[TBL] [Abstract][Full Text] [Related]
93. Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules.
De Feo ML; Colagrande S; Biagini C; Tonarelli A; Bisi G; Vaggelli L; Borrelli D; Cicchi P; Tonelli F; Amorosi A; Serio M; Brandi ML
Radiology; 2000 Feb; 214(2):393-402. PubMed ID: 10671586
[TBL] [Abstract][Full Text] [Related]
94. Nonequivalent results of tetrofosmin and sestamibi imaging of parathyroid tumors.
Harrell RM; Mackman DM; Bimston DN
Endocr Pract; 2006; 12(2):179-82. PubMed ID: 16690467
[TBL] [Abstract][Full Text] [Related]
95. Validity of dual tracer 99mTc-tetrofosmin and 99mTc-pertechnetate subtraction parathyroid scintigraphy in patients with primary and secondary hyperparathyroidism.
Dugonjić S; Ajdinović B; Cerović S; Janković Z
Vojnosanit Pregl; 2009 Dec; 66(12):949-53. PubMed ID: 20095513
[TBL] [Abstract][Full Text] [Related]
96. Comparison of parathyroid scintigraphy findings in pediatric and adult patients with secondary hyperparathyroidism.
Aktaş A; Baskin E; Gençoğlu EA; Çolak T
Nucl Med Commun; 2023 Oct; 44(10):860-863. PubMed ID: 37503712
[TBL] [Abstract][Full Text] [Related]
97. Parathyroid adenoma detected with 99mTc-tetrofosmin dual-phase scintigraphy: a case report.
Romanidis K; Karathanos E; Nagorni EA; Giatromanolaki A; Sibridis E; Zissimopoulos A; Vogiatzaki T; Simopoulos C; Pitiakoudis M
BMC Res Notes; 2014 Jun; 7():335. PubMed ID: 24894734
[TBL] [Abstract][Full Text] [Related]
98. Parathyroid gland radionuclide scanning--methods and indications.
Hindié E; de LV; Mellière D; Jeanguillaume C; Urena P; Perlemuter L; Askienazy S
Joint Bone Spine; 2002 Jan; 69(1):28-36. PubMed ID: 11858353
[TBL] [Abstract][Full Text] [Related]
99. Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines.
Perek N; Prevot N; Koumanov F; Frere D; Sabido O; Beauchesne P; Dubois F
Nucl Med Biol; 2000 Apr; 27(3):299-307. PubMed ID: 10832087
[TBL] [Abstract][Full Text] [Related]
100. Parathyroid Scintigraphy with an Incidental Indirect Finding of Pancreatic Cancer.
Nguyen BD
J Nucl Med Technol; 2021 Jun; 49(2):188-189. PubMed ID: 33219157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
